WO2007123883A3 - Oral dosage formulations and methods of preparing the same - Google Patents
Oral dosage formulations and methods of preparing the same Download PDFInfo
- Publication number
- WO2007123883A3 WO2007123883A3 PCT/US2007/009331 US2007009331W WO2007123883A3 WO 2007123883 A3 WO2007123883 A3 WO 2007123883A3 US 2007009331 W US2007009331 W US 2007009331W WO 2007123883 A3 WO2007123883 A3 WO 2007123883A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- oral dosage
- dosage form
- preparing
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Disclosed herein are methods and compositions suitable for providing zero-order release of active agents. Disclosed herein is a multiparticulate oral dosage form comprising a plurality of pulsed-release pellets, wherein the dosage form releases the active agent at a substantially constant rate following a lag time. The dosage form comprises a combination ensemble of pellets produced by combining 2 to 8 individual ensembles of pulsed-release pellets having a particular T50 and dissolution profile.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07755562A EP2010161A2 (en) | 2006-04-17 | 2007-04-17 | Oral dosage formulations and methods of preparing the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79244206P | 2006-04-17 | 2006-04-17 | |
US60/792,442 | 2006-04-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007123883A2 WO2007123883A2 (en) | 2007-11-01 |
WO2007123883A3 true WO2007123883A3 (en) | 2008-03-27 |
Family
ID=38537695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/009331 WO2007123883A2 (en) | 2006-04-17 | 2007-04-17 | Oral dosage formulations and methods of preparing the same |
Country Status (3)
Country | Link |
---|---|
US (2) | US20070243252A1 (en) |
EP (1) | EP2010161A2 (en) |
WO (1) | WO2007123883A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1551372T3 (en) | 2002-09-20 | 2018-07-23 | Alpharma Pharmaceuticals Llc | SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES |
WO2007149438A2 (en) | 2006-06-19 | 2007-12-27 | Alpharma, Inc. | Pharmaceutical compositions |
WO2008063301A2 (en) * | 2006-10-11 | 2008-05-29 | Alpharma, Inc. | Pharmaceutical compositions |
US8623418B2 (en) | 2007-12-17 | 2014-01-07 | Alpharma Pharmaceuticals Llc | Pharmaceutical composition |
EP2293782B1 (en) * | 2008-05-06 | 2015-08-12 | Dexcel Pharma Technologies Ltd. | Stable benzimidazole formulation |
TWI590821B (en) * | 2011-01-18 | 2017-07-11 | 輝瑞有限公司 | Solid molecular dispersion |
US20210145777A1 (en) * | 2017-06-16 | 2021-05-20 | Altibio, Inc. | Modified-release tiopronin compositions, kits and methods for treating cystinuria and related disorders |
CN114425046B (en) * | 2021-12-16 | 2023-10-20 | 南通联亚药业股份有限公司 | Diltiazem hydrochloride sustained-release capsule |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0365947A1 (en) * | 1988-10-26 | 1990-05-02 | Dib Limited | Novel dosage form |
WO1998051287A1 (en) * | 1997-05-15 | 1998-11-19 | Bai Jane Pei Fan | Pulsatile drug delivery system |
WO2000025752A1 (en) * | 1998-11-02 | 2000-05-11 | Church, Marla, J. | Multiparticulate modified release composition |
WO2004045589A1 (en) * | 2002-11-15 | 2004-06-03 | Elan Pharmaceuticals, Inc. | Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5202128A (en) * | 1989-01-06 | 1993-04-13 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
US5580578A (en) * | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5260068A (en) * | 1992-05-04 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Multiparticulate pulsatile drug delivery system |
US5834024A (en) * | 1995-01-05 | 1998-11-10 | Fh Faulding & Co. Limited | Controlled absorption diltiazem pharmaceutical formulation |
US6368628B1 (en) * | 2000-05-26 | 2002-04-09 | Pharma Pass Llc | Sustained release pharmaceutical composition free of food effect |
PL1638529T3 (en) * | 2003-06-16 | 2017-03-31 | Andrx Pharmaceuticals, Llc. | Oral extended-release composition |
-
2007
- 2007-04-17 WO PCT/US2007/009331 patent/WO2007123883A2/en active Application Filing
- 2007-04-17 US US11/736,048 patent/US20070243252A1/en not_active Abandoned
- 2007-04-17 EP EP07755562A patent/EP2010161A2/en not_active Withdrawn
- 2007-04-17 US US11/736,113 patent/US20070243250A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0365947A1 (en) * | 1988-10-26 | 1990-05-02 | Dib Limited | Novel dosage form |
WO1998051287A1 (en) * | 1997-05-15 | 1998-11-19 | Bai Jane Pei Fan | Pulsatile drug delivery system |
WO2000025752A1 (en) * | 1998-11-02 | 2000-05-11 | Church, Marla, J. | Multiparticulate modified release composition |
WO2004045589A1 (en) * | 2002-11-15 | 2004-06-03 | Elan Pharmaceuticals, Inc. | Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders |
Also Published As
Publication number | Publication date |
---|---|
EP2010161A2 (en) | 2009-01-07 |
WO2007123883A2 (en) | 2007-11-01 |
US20070243252A1 (en) | 2007-10-18 |
US20070243250A1 (en) | 2007-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007123883A3 (en) | Oral dosage formulations and methods of preparing the same | |
CA3094580C (en) | Oral formulations of cytidine analogs and methods of use thereof | |
WO2007002013A3 (en) | Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use | |
WO2005070462A3 (en) | Compositions comprising (s)-amlodipine and an angiotensin receptor blocker and methods of their use | |
WO2004062577A3 (en) | Two or more enteric materials to regulate drug release | |
WO2011084593A3 (en) | Abuse-resistant formulations | |
WO2008027557A3 (en) | Topiramate compositions and methods of enhancing its bioavailability | |
MY136524A (en) | New solid pharmaceutical formulations comprising telmisartan and preparation thereof | |
CY1111470T1 (en) | NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLYVERSERIN POLYMORPH A | |
WO2007090882A3 (en) | Pharmaceutical extended release compositions comprising pramipexole | |
AU2003270255A1 (en) | Fast releasing, solid administration form for oral application of active ingredients which are hard to dissolve | |
TW200833372A (en) | Use of (meth)acrylate copolymers in delayed-release pharmaceutical forms for decreasing the influence of ethanol on the release of active compound | |
WO2007044796A3 (en) | Pyridazinone compounds as calcilytics | |
WO2008052033A3 (en) | Ibuprofen composition | |
IL174830A0 (en) | Pellets containing venlafaxine hydrochloride, pharmaceutical compositions comprising them and processes for their preparation | |
UA93709C2 (en) | 12-imidazolyl-1-dodecanol and use thereof in the preparation of pharmaceutical compositions | |
UA96622C2 (en) | Solid dosage forms comprising aliskiren obtained by solvent-free granulation process | |
UA87515C2 (en) | Sustained release pharmaceutical composition of tolterodine | |
NO20013060D0 (en) | Controlled release pharmaceutical preparation with tilidine mesylate as active ingredient | |
MX2007014963A (en) | Modified-release composition of at least one form of venlafaxine. | |
WO2008013860A3 (en) | Acyloxyalkyl carbamate prodrugs of alpha-amino acids, methods of synthesis and use | |
WO2010044097A3 (en) | Novel dosage form of paliperidone and process for preparing the same | |
WO2011047837A3 (en) | Melt-granulated cinacalcet | |
WO2008060546A3 (en) | Oral formulations | |
WO2009084041A3 (en) | Pharmaceutical compositions of dexibuprofen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07755562 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007755562 Country of ref document: EP |